Chemoinformaics analysis of 5,6,7,8-TETRAMETHOXY-2-(4-METHOXYPHENYL)CHROMEN-4-ONE
| Molecular Weight | 372.373 | nRot | 6 |
| Heavy Atom Molecular Weight | 352.213 | nRig | 18 |
| Exact Molecular Weight | 372.121 | nRing | 3 |
| Solubility: LogS | -4.58 | nHRing | 1 |
| Solubility: LogP | 3.232 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 52.3499 |
| nHD | 0 | BPOL | 31.3481 |
| QED | 0.655 |
| Synth | 2.374 |
| Natural Product Likeliness | 0.831 |
| NR-PPAR-gamma | 0.047 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 1 |
| Pgp-sub | 0 |
| HIA | 0.01 |
| CACO-2 | -4.504 |
| MDCK | 0.0000326 |
| BBB | 0.061 |
| PPB | 0.731363 |
| VDSS | 0.921 |
| FU | 0.245579 |
| CYP1A2-inh | 0.38 |
| CYP1A2-sub | 0.98 |
| CYP2c19-inh | 0.829 |
| CYP2c19-sub | 0.871 |
| CYP2c9-inh | 0.847 |
| CYP2c9-sub | 0.923 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.916 |
| CYP3a4-inh | 0.529 |
| CYP3a4-sub | 0.787 |
| CL | 3.949 |
| T12 | 0.225 |
| hERG | 0.318 |
| Ames | 0.432 |
| ROA | 0.352 |
| SkinSen | 0.257 |
| Carcinogencity | 0.083 |
| EI | 0.08 |
| Respiratory | 0.032 |
| NR-Aromatase | 0.871 |
| Antiviral | Yes |
| Prediction | 0.975223 |